111 related articles for article (PubMed ID: 15095618)
1. [Wnt/LRP5, a new regulation osteoblastic pathway involved in reaching peak bone masses].
Caverzasio J
Rev Med Suisse Romande; 2004 Feb; 124(2):81-2. PubMed ID: 15095618
[TBL] [Abstract][Full Text] [Related]
2. The high bone mass family--the role of Wnt/Lrp5 signaling in the regulation of bone mass.
Johnson ML
J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):135-8. PubMed ID: 15615112
[TBL] [Abstract][Full Text] [Related]
3. [Wnt-beta-catenin signaling in bone metabolism].
Urano T
Clin Calcium; 2006 Jan; 16(1):54-60. PubMed ID: 16397351
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling in osteoblasts and bone diseases.
Westendorf JJ; Kahler RA; Schroeder TM
Gene; 2004 Oct; 341():19-39. PubMed ID: 15474285
[TBL] [Abstract][Full Text] [Related]
5. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton.
Koay MA; Brown MA
Trends Mol Med; 2005 Mar; 11(3):129-37. PubMed ID: 15760771
[TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.
Li ZG; Yang J; Vazquez ES; Rose D; Vakar-Lopez F; Mathew P; Lopez A; Logothetis CJ; Lin SH; Navone NM
Oncogene; 2008 Jan; 27(5):596-603. PubMed ID: 17700537
[TBL] [Abstract][Full Text] [Related]
7. Expression, purification and functional characterization of Wnt signaling co-receptors LRP5 and LRP6.
Fleury D; Vayssiere B; Touitou R; Gillard C; Lebhar H; Rawadi G; Mollat P
Protein Expr Purif; 2010 Mar; 70(1):39-47. PubMed ID: 19716419
[TBL] [Abstract][Full Text] [Related]
8. Lrp5 and bone formation : A serotonin-dependent pathway.
Yadav VK; Ducy P
Ann N Y Acad Sci; 2010 Mar; 1192():103-9. PubMed ID: 20392224
[TBL] [Abstract][Full Text] [Related]
9. Influence of an LRP5 cytoplasmic SNP on Wnt signaling and osteoblastic differentiation.
Guo J; Cooper LF
Bone; 2007 Jan; 40(1):57-67. PubMed ID: 16956801
[TBL] [Abstract][Full Text] [Related]
10. The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations.
Balemans W; Piters E; Cleiren E; Ai M; Van Wesenbeeck L; Warman ML; Van Hul W
Calcif Tissue Int; 2008 Jun; 82(6):445-53. PubMed ID: 18521528
[TBL] [Abstract][Full Text] [Related]
11. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells.
Boland GM; Perkins G; Hall DJ; Tuan RS
J Cell Biochem; 2004 Dec; 93(6):1210-30. PubMed ID: 15486964
[TBL] [Abstract][Full Text] [Related]
12. Wnt signaling: a key regulator of bone mass.
Baron R; Rawadi G; Roman-Roman S
Curr Top Dev Biol; 2006; 76():103-27. PubMed ID: 17118265
[TBL] [Abstract][Full Text] [Related]
13. [Wnt signaling and bone metabolism].
Asaba H; Sakai J
Clin Calcium; 2005 May; 15(5):813-8. PubMed ID: 15876744
[TBL] [Abstract][Full Text] [Related]
14. Effects of parathyroid hormone on Wnt signaling pathway in bone.
Kulkarni NH; Halladay DL; Miles RR; Gilbert LM; Frolik CA; Galvin RJ; Martin TJ; Gillespie MT; Onyia JE
J Cell Biochem; 2005 Aug; 95(6):1178-90. PubMed ID: 15962290
[TBL] [Abstract][Full Text] [Related]
15. [Cytokines in bone diseases. Wnt signal and excessive bone formation].
Hosoi T
Clin Calcium; 2010 Oct; 20(10):1526-31. PubMed ID: 20890035
[TBL] [Abstract][Full Text] [Related]
16. The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes.
Balemans W; Van Hul W
Endocrinology; 2007 Jun; 148(6):2622-9. PubMed ID: 17395706
[TBL] [Abstract][Full Text] [Related]
17. Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signaling.
Bhat BM; Allen KM; Liu W; Graham J; Morales A; Anisowicz A; Lam HS; McCauley C; Coleburn V; Cain M; Fortier E; Bhat RA; Bex FJ; Yaworsky PJ
Gene; 2007 Apr; 391(1-2):103-12. PubMed ID: 17276019
[TBL] [Abstract][Full Text] [Related]
18. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone].
Kobayashi T
Clin Calcium; 2009 Jul; 19(7):911-8. PubMed ID: 19567985
[TBL] [Abstract][Full Text] [Related]
19. A new paradigm in the treatment of osteoporosis: Wnt pathway proteins and their antagonists.
Chan A; van Bezooijen RL; Löwik CW
Curr Opin Investig Drugs; 2007 Apr; 8(4):293-8. PubMed ID: 17458178
[TBL] [Abstract][Full Text] [Related]
20. The Wnt co-receptors Lrp5 and Lrp6 are essential for gastrulation in mice.
Kelly OG; Pinson KI; Skarnes WC
Development; 2004 Jun; 131(12):2803-15. PubMed ID: 15142971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
